Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TAM”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT03664895
What this trial is testing

Density Lowering Effect of "OFS Add on to TMX"(DELFINO Trial)

Who this might be right for
Breast Cancer Invasive
Seoul National University Hospital 224
Large-scale testing (Phase 3)WithdrawnNCT00411281
What this trial is testing

Low-Dose Cytarabine in Treating Infants With Down Syndrome and Transient Myeloproliferative Disorder

Who this might be right for
Leukemia
Children's Oncology Group
Not applicableStudy completedNCT00165308
What this trial is testing

Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease Survivors

Who this might be right for
Hodgkin's DiseaseBreast Cancer
Dana-Farber Cancer Institute 29
Large-scale testing (Phase 3)UnknownNCT01352091
What this trial is testing

Adjuvant AI Combined With Zoladex

Who this might be right for
Breast Cancer
Fudan University 670
Testing effectiveness (Phase 2)Study completedNCT00118157
What this trial is testing

Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen

Who this might be right for
Estrogen Receptor PositiveMale Breast CarcinomaProgesterone Receptor Positive+4 more
National Cancer Institute (NCI) 19
Not applicableLooking for participantsNCT07279480
What this trial is testing

Communication and Health Investments for Elderly Women

Who this might be right for
Take-up of Preventative CareCommunication About Health Information
Abdul Latif Jameel Poverty Action Lab 1,200
Not applicableStudy completedNCT01334996
What this trial is testing

Use of Tamoxifen in Systemic Mastocytosis

Who this might be right for
Systemic Mastocytosis
Mayo Clinic 1
Large-scale testing (Phase 3)Study completedNCT00784862
What this trial is testing

ATAC - Pharmacokinetics (PK) Sub-Protocol

Who this might be right for
Breast Cancer
AstraZeneca 9,358
Testing effectiveness (Phase 2)Study completedNCT02988986
What this trial is testing

TAK-228 Plus Tamoxifen in Patients With ER-Positive, HER2-negative Breast Cancer

Who this might be right for
Estrogen Receptor Positive Breast Cancer
The Methodist Hospital Research Institute 28
Not applicableUnknownNCT04116827
What this trial is testing

Sleep and Activity Patterns in Pre-menopausal Breast Cancer Patients on Tamoxifen Using a Wrist-worn Internet of Things Device

Who this might be right for
Sleep DisorderBreast Cancer
Samsung Medical Center 20
Large-scale testing (Phase 3)UnknownNCT05016349
What this trial is testing

Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.

Who this might be right for
Breast Cancer Female
Mahmoud Ramadan mohamed Elkazzaz 160
Not applicableStudy completedNCT03898947
What this trial is testing

Endometrial Changes in Breast Cancer Women With or Without Hormonal Therapies

Who this might be right for
Breast CancerEndometrial Cancer
Università degli Studi dell'Insubria 1,329
Post-approval studies (Phase 4)Study completedNCT01127295
What this trial is testing

Pharmacology of Adjuvant Hormonotherapy in Breast Cancer

Who this might be right for
Hormono-depending Adjuvant Breast Cancer
Institut Claudius Regaud 2,000
Large-scale testing (Phase 3)UnknownNCT00896155
What this trial is testing

Trial of Concurrent Versus Sequential Tamoxifen With Radiotherapy in Breast Cancer Patients

Who this might be right for
Pulmonary FibrosisBreast Cancer
Tata Memorial Hospital 260
Testing effectiveness (Phase 2)Study completedNCT00214110
What this trial is testing

Tamoxifen Therapy in Amyotrophic Lateral Sclerosis [ALS]

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
University of Wisconsin, Madison 100
Testing effectiveness (Phase 2)Study completedNCT01298713
What this trial is testing

Tamoxifen-RAD001 Versus Tamoxifen Alone in Patients With Anti-aromatase Resistant Breast Metastatic Cancer

Who this might be right for
Breast NeoplasmsmTor Protein
ARCAGY/ GINECO GROUP 111
Testing effectiveness (Phase 2)Study completedNCT02970682
What this trial is testing

SFX-01 in the Treatment and Evaluation of Metastatic Breast Cancer

Who this might be right for
Breast Neoplasm
Evgen Pharma 60
Early research (Phase 1)Study completedNCT02058381
What this trial is testing

A Phase Ib Dose De-escalation Study With BYL719 in Premenopausal Patients With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Pre-menopausal Breast CancerPI3K Pathway Inhibition
Novartis Pharmaceuticals 40
Not applicableStudy completedNCT01582074
What this trial is testing

The Ultrasound Study of Tamoxifen

Who this might be right for
Breast Neoplasms
National Cancer Institute (NCI) 247
Testing effectiveness (Phase 2)UnknownNCT03879174
What this trial is testing

Pembrolizumab And Tamoxifen Among Women With Advanced Hormone Receptor Positive Breast Cancer And Esr1 Mutation

Who this might be right for
Breast Cancer Female
Mediclinic Middle East 25
Next Page